Swedencare AB (publ)

OM:SECARE Stock Report

Market Cap: SEK 4.1b

Swedencare Future Growth

Future criteria checks 4/6

Swedencare is forecast to grow earnings and revenue by 50.2% and 9.1% per annum respectively. EPS is expected to grow by 49.8% per annum. Return on equity is forecast to be 3.6% in 3 years.

Key information

50.2%

Earnings growth rate

49.78%

EPS growth rate

Pharmaceuticals earnings growth37.7%
Revenue growth rate9.1%
Future return on equity3.61%
Analyst coverage

Low

Last updated02 Jun 2026

Recent future growth updates

Analysis Article • Feb 15

Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next

Last week saw the newest yearly earnings release from Swedencare AB (publ) ( STO:SECARE ), an important milestone in...

Recent updates

Narrative Update • Jun 26

SECARE: I Expect Slower Acquisitions To Set Up A 2027 Upswing

Analysts have trimmed their Swedencare price target from SEK 55.00 to SEK 45.00, citing updated assumptions that now reflect a slightly higher discount rate, modestly lower revenue growth expectations, a higher projected profit margin, and a reduced future P/E multiple. What’s in the News for Swedencare Swedencare is actively seeking acquisitions, with management highlighting ongoing interest in adding new features and capabilities to the group.
Analysis Article • May 01

Swedencare's (STO:SECARE) Soft Earnings Are Actually Better Than They Appear

Shareholders appeared unconcerned with Swedencare AB (publ)'s ( STO:SECARE ) lackluster earnings report last week. We...
New Narrative • Feb 22

Online And Pharma Execution Risks Will Test Pet Health Upside Potential

Catalysts About Swedencare Swedencare develops and sells pet health products across dental care, nutraceuticals, treats and veterinary pharma, with a growing focus on online and Big Box retail channels. What are the underlying business or industry changes driving this perspective?
Analysis Article • Feb 15

Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next

Last week saw the newest yearly earnings release from Swedencare AB (publ) ( STO:SECARE ), an important milestone in...
New Narrative • Feb 07

The Compound Effect: From Acquisition to Integration

In 2026, the story is no longer about how many companies Swedencare can buy, but how effectively it can scale its existing brands (ProDen PlaqueOff and NaturVet) into global Big Box retail and e-commerce The Pet Humanization Play Swedencare's narrative rests on three pillars: The Global Brand Portfolio: Moving from a single product company to a diversified pet health giant. The story is about cross-selling, taking a successful dental product from Sweden and putting it in 2,000 Walmart stores in the US The Channel Pivot: Swedencare is taking direct control of its destiny by moving Amazon sales inhouse and entering Big Box retail like Walmart, CVS etc.
New Narrative • Feb 04

Big Box Expansion And Soft Chew Capacity Will Transform Long Term Pet Health Prospects

Catalysts About Swedencare Swedencare develops and sells pet health products and provides contract development and manufacturing services to animal health companies. What are the underlying business or industry changes driving this perspective?
Analysis Article • Feb 01

With A 37% Price Drop For Swedencare AB (publ) (STO:SECARE) You'll Still Get What You Pay For

The Swedencare AB (publ) ( STO:SECARE ) share price has fared very poorly over the last month, falling by a substantial...
Analysis Article • Oct 30

We Think Swedencare's (STO:SECARE) Solid Earnings Are Understated

Investors signalled that they were pleased with Swedencare AB (publ)'s ( STO:SECARE ) most recent earnings report...
Analysis Article • Jul 26

Swedencare AB (publ) Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

It's been a mediocre week for Swedencare AB (publ) ( STO:SECARE ) shareholders, with the stock dropping 15% to kr39.75...
User avatar
New Narrative • Feb 19

Resolving NaturVet's Challenges And Global Expansion Will Enhance Future Opportunities

Improved growth strategy for NaturVet and global market expansion aim to enhance revenue and achieve group targets.
Analysis Article • Apr 29

Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Earnings and Revenue Growth Forecasts

OM:SECARE - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,4113075555843
12/31/20273,1242284764963
12/31/20262,8531463874013
3/31/20262,70049244295N/A
12/31/20252,69156276327N/A
9/30/20252,67563313364N/A
6/30/20252,60365292337N/A
3/31/20252,58293310385N/A
12/31/20242,53699288359N/A
9/30/20242,50462338404N/A
6/30/20242,47276351414N/A
3/31/20242,41472381415N/A
12/31/20232,33859408444N/A
9/30/20232,20887410444N/A
6/30/20232,08553332376N/A
3/31/20231,98797257314N/A
12/31/20221,84395193260N/A
9/30/20221,6009896170N/A
6/30/20221,33510569135N/A
3/31/20221,01960114161N/A
12/31/20217735598126N/A
9/30/20216184090106N/A
6/30/2021465447479N/A
3/31/2021337344548N/A
12/31/2020240333637N/A
9/30/2020174342629N/A
6/30/2020136282831N/A
3/31/2020134302024N/A
12/31/201912730N/A33N/A
9/30/201912130N/A32N/A
6/30/201911328N/A30N/A
3/31/201910827N/A28N/A
12/31/20189923N/A22N/A
9/30/20189423N/A21N/A
6/30/20189220N/A15N/A
3/31/20188517N/A14N/A
12/31/20178617N/A13N/A
9/30/20177812N/A4N/A
6/30/20177011N/A4N/A
3/31/20176312N/A4N/A
12/31/20165410N/A2N/A
9/30/2016439N/A8N/A
6/30/2016378N/A9N/A
3/31/2016348N/A5N/A
12/31/2015277N/A4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SECARE's forecast earnings growth (50.2% per year) is above the savings rate (2%).

Earnings vs Market: SECARE's earnings (50.2% per year) are forecast to grow faster than the Swedish market (8.6% per year).

High Growth Earnings: SECARE's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SECARE's revenue (9.1% per year) is forecast to grow faster than the Swedish market (-0.3% per year).

High Growth Revenue: SECARE's revenue (9.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SECARE's Return on Equity is forecast to be low in 3 years time (3.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/02 00:16
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Swedencare AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan BrownABG Sundal Collier Sponsored
Adela DashianJefferies LLC
Adrian ElmlundNordea Markets